Pemphigus Vulgaris
📧 Sign up to get email alerts when something new happens for Pemphigus Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Autoimmune Blistering Diseases Study
This clinical trial update from the University of Pennsylvania indicates the study is currently recruiting for autoimmune blistering disease…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients
A clinical trial is studying periodontal status and disease severity in Pemphigus vulgaris patients. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV) [Phase 1, Phase 2]
A Phase 1/2 open-label study evaluating autologous CAR-T therapies DSG3-CAART and CABA-201 for active pemphigus vulgaris; the trial is curre…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients. [NA]
This document reports a clinical trial evaluating low-level laser therapy for oral involvement in Pemphigus vulgaris; the study is not yet r…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation.
Clinical study evaluating trichoscopy as a monitoring tool for activity and remission in pemphigus vulgaris, supported by immunological eval…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313. [Phase 1, Phase 2]
This document describes a randomized Phase 1/2 clinical trial evaluating CM313, a humanized CD38 antibody, for Pemphigus vulgaris; the study…
-
CLINICAL_TRIALS research · 2024-09-03Clinical Trial Update: Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. [Phase 1]
Open-label Phase 1 study evaluating the safety and preliminary efficacy of combining Rituximab with AB-101 in B-cell–associated autoimmune d…
-
CLINICAL_TRIALS research · 2017-06-06Clinical Trial Update: Serum IL-21 Levels in Patients With Pemphigus Vulgaris
This clinical trial update examines serum IL-21 levels in patients with Pemphigus Vulgaris; the current status of the study is unknown.